Insomnia – Pipeline Review, H1 2013Global Markets DirectFebruary 28, 2013 87 Pages - SKU: GMD4986648 |
- Introduction
- Global Markets Direct Report Coverage
- Insomnia Overview
- Therapeutics Development
- An Overview of Pipeline Products for Insomnia
- Insomnia Therapeutics under Development by Companies
- Insomnia Therapeutics under Investigation by Universities/Institutes
- Late Stage Products
- Comparative Analysis
- Mid Clinical Stage Products
- Comparative Analysis
- Early Clinical Stage Products
- Comparative Analysis
- Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Insomnia Therapeutics – Products under Development by Companies
- Companies Involved in Insomnia Therapeutics Development
- Merck & Co., Inc.
- Alexza Pharmaceuticals, Inc.
- Actelion Ltd
- Eisai Co., Ltd.
- Mitsubishi Tanabe Pharma Corporation
- Evotec Aktiengesellschaft
- IntelGenx Technologies Corp.
- Neurim Pharmaceuticals (1991) Ltd.
- Intas Pharmaceuticals Ltd.
- Angelini Group
- Abeille Pharmaceuticals, Inc.
- Intec Pharma ltd.
- Ferrer Internacional S.A.
- Somnus Therapeutics, Inc.
- Intra-Cellular Therapies, Inc.
- Kuhnil Pharmaceutical Co., Ltd.
- Heptares Therapeutics Ltd.
- Insomnia – Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Drug Profiles
- suvorexant - Drug Profile
- zaleplon - Drug Profile
- Neu-P11 - Drug Profile
- AB-1003 - Drug Profile
- MKC-242 - Drug Profile
- zaleplon - Drug Profile
- EVT-201 - Drug Profile
- Orexin-2 - Drug Profile
- ITI-007 - Drug Profile
- filorexant - Drug Profile
- zaleplon - Drug Profile
- MK-3697 - Drug Profile
- INAQUL-001 - Drug Profile
- INT-0020 - Drug Profile
- Drug Targeting Orexin 1/2 - Drug Profile
- E-2006 - Drug Profile
- trazodone hydrochloride - Drug Profile
- UCM-765 - Drug Profile
- Orexin Receptor Antagonist - Drug Profile
- lorediplon - Drug Profile
- KI-1001 - Drug Profile
- Orexin-1 Antagonist - Drug Profile
- Insomnia Therapeutics – Drug Profile Updates
- Insomnia Therapeutics – Discontinued Products
- Insomnia Therapeutics - Dormant Products
- Insomnia – Product Development Milestones
- Featured News & Press Releases
- Appendix
- Methodology
- Coverage
- Secondary Research
- Primary Research
- Expert Panel Validation
- Contact Us
- Disclaimer
- List of Tables
- Number of Products Under Development for Insomnia, H1 2013
- Products under Development for Insomnia – Comparative Analysis, H1 2013
- Number of Products under Development by Companies, H1 2013
- Number of Products under Development by Companies, H1 2013 (Contd..1)
- Number of Products under Investigation by Universities/Institutes, H1 2013
- Comparative Analysis by Late Stage Development, H1 2013
- Comparative Analysis by Mid Clinical Stage Development, H1 2013
- Comparative Analysis by Early Clinical Stage Development, H1 2013
- Comparative Analysis by Discovery and Pre-Clinical Stage Development, H1 2013
- Products under Development by Companies, H1 2013
- Products under Development by Companies, H1 2013 (Contd..1)
- Merck & Co., Inc., H1 2013
- Alexza Pharmaceuticals, Inc., H1 2013
- Actelion Ltd, H1 2013
- Eisai Co., Ltd., H1 2013
- Mitsubishi Tanabe Pharma Corporation, H1 2013
- Evotec Aktiengesellschaft, H1 2013
- IntelGenx Technologies Corp., H1 2013
- Neurim Pharmaceuticals (1991) Ltd., H1 2013
- Intas Pharmaceuticals Ltd., H1 2013
- Angelini Group, H1 2013
- Abeille Pharmaceuticals, Inc., H1 2013
- Intec Pharma ltd., H1 2013
- Ferrer Internacional S.A., H1 2013
- Somnus Therapeutics, Inc., H1 2013
- Intra-Cellular Therapies, Inc., H1 2013
- Kuhnil Pharmaceutical Co., Ltd., H1 2013
- Heptares Therapeutics Ltd., H1 2013
- Assessment by Monotherapy Products, H1 2013
- Assessment by Stage and Route of Administration, H1 2013
- Assessment by Stage and Molecule Type, H1 2013
- Insomnia Therapeutics – Drug Profile Updates
- Insomnia Therapeutics – Discontinued Products
- Insomnia Therapeutics – Discontinued Products (Contd..1)
- Insomnia Therapeutics – Dormant Products
- Insomnia Therapeutics – Dormant Products (Contd..1)
- List of Figures
- Number of Products under Development for Insomnia, H1 2013
- Products under Development for Insomnia – Comparative Analysis, H1 2013
- Products under Development by Companies, H1 2013
- Products under Investigation by Universities/Institutes, H1 2013
- Late Stage Products, H1 2013
- Mid Clinical Stage Products, H1 2013
- Early Clinical Stage Products, H1 2013
- Discovery and Pre-Clinical Stage Products, H1 2013
- Assessment by Monotherapy Products, H1 2013
- Assessment by Route of Administration, H1 2013
- Assessment by Stage and Route of Administration, H1 2013
- Assessment by Molecule Type, H1 2013
- Assessment by Stage and Molecule Type, H1 2013
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Drug Discovery Reports